Fate Therapeutics (FATE) PT Raised to $31 at SVB Leerink
Tweet
Share
E-mailGet Alerts FATE Hot Sheet
Price: $2.62 +1.95%
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
SVB Leerink analyst Daina Graybosch raised the price target on Fate Therapeutics (NASDAQ: FATE) to $31.00 (from $20.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Fate Therapeutics (FATE) PT Raised to $3.50 at Wells Fargo
- Fate Therapeutics starts Phase 2 lupus nephritis trial of FT819
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
